Prostate cancer is not terrible

*For medical professionals for reading reference

Prostate cancer refers to epithelial malignant tumors that occur in prostate. According to the definition of "Pathology and Genetics and Genetics" of WHO's "Urinary System and Male Reproductive organs", prostate cancer pathological types include: adenocarcinoma (adenocarcinoma), duct adenocarcinoma, urinary epithelial cancer, squamous cell carcinoma, glands, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, glandular, adrenal Syntoma carcinoma. Among them, prostate gland cancer accounts for more than 95%, so generally we call prostate cancer refers to prostate cancer.

Prostate cancer is one of the common tumors that threaten men's health, and the second place in male tumors. Penal cancer in developed countries accounts for 19% of new cases of tumor, while only 5.3% in developing countries. Although China is a low -developed country of prostate cancer compared with developed countries, its incidence has risen steadily in recent years [1], which makes many men worry. So, is prostate cancer really terrible?

In fact, prostate cancer is not terrible. Prostate cancer is a "chronic" malignant tumor. It grows slowly. If prostate cancer can be found early, the cure rate is very high. Unfortunately, most patients in my country have metastasized when diagnosed prostate cancer. At this time, the lesions are late and the prognosis is poor. There are two main methods for the preliminary screening of prostate cancer internationally, and these two methods are the most commonly used methods for prostate cancer screening: the level of blood PSA and rectal fingerprints.

The prostate rectal test is the easiest way to test, which can help doctors easily understand the shape, size, hardness, hardness, smooth surface of the prostate. It should also be suspected that prostate cancer may be performed, and further examination needs to be performed. For example, after the rectal prostate ultrasound test or nuclear magnetic examination, the size and properties of the mass can be clarified.

Prostate special antigen (PSA) is a lingedine protease produced by prostate epithelial cells and is directly secreted into the prostate duct system. Under normal circumstances, due to the natural barrier of prostate tissue on high -level PSA, the PSA content in serum is very small. However, if the prostate tissue has a lesion and rupture, a large number of PSA [2] will be released in the serum. Blood PSA examination is to use patients with venous blood to test. PSAs of patients with prostate cancer are much higher than ordinary people. Therefore, when the blood PSA rises, we must be alert to whether there is prostate cancer.

When the patient is diagnosed with prostate cancer, it needs to be treated in time. Based on the progress of prostate cancer and the patient's physical condition comprehensively determines the treatment plan. At present, the treatment of prostate cancer can be divided into prostate root treatment, radiation smelting, endocrine therapy, chemotherapy and other methods.

The screening of high -risk people in prostate cancer and early diagnosis of patients are essential to increase the cure rate of prostate cancer. However, according to the "Chinese Prostate Cancer Screening and Early Creed Early Treatment Guidelines (2022)", compared with unbiased, the potential negative effects produced by individuals or groups during the process of participating in prostate cancer have four aspects: Screening false positive, over -diagnosis, over -treatment, and related psychological effects [3]. Therefore, the age and physical condition should be considered before deciding whether to conduct a screening, and the decision with the doctor should be discussed with the doctor according to the specific situation.

In addition to considering regular screening, in daily life, you can also prevent exercise, low fat in diet, and pay attention to personal hygiene in private parts to prevent prostate cancer. As long as daily life is maintained, high -risk people screen as soon as possible, prostate cancer is not terrible!

references:

[1]. Yu Shiying, Hu Guoqing Tumor Clinical Diagnosis and Treatment Guide [M] 3 version Beijing: Science Press, 2013: 265

[2]. Zhou Yanping, Huang Yongjin. The application of the prostate special antigen in the early screening of prostate cancer [J]. International urinary system magazine, 2013,33 (2): 233-237. Doi: 10.3760/cma.issnnnnn .1673-4416.2013.02.029.

[3]. He Jie, Chen Wanqing, Li Ni, Cao Wei, Ye Dingwei, Ma Jianhui, Xing Nianzheng, Peng Ji, Tian Jinhui, Chinese prostate cancer screening and early diagnosis and early treatment guideline formulation expert group, Chinese prostate cancer screening and early consultation early early diagnosis Treatment of Guidelines for Working Group. China's Prostate Cancer Screening and Early Creed Prereal Guide (2022, Beijing) [J]. Chinese Oncology Magazine, 2022,44 (1): 29-53.doi: 10.3760/cma.j.cn112152 -20211226-00975.

CN101077, Expiration date: 2022-9-29

*This material is supported by Astrikon, for reference for medical and health professionals

*This article is only used to provide scientific information to medical people, and does not represent the viewpoint of this platform

- END -